Pioneering next-generation exosome therapeutics  ·  Explore Our Science →

Contact Us

Building the future of exosome medicine—together. Reach out to discuss partnerships, careers, or media inquiries.

Partner With P.S.K Biosciences

P.S.K Biosciences is developing next-generation exosome platforms for RNA delivery, CNS and extrahepatic targeting, inflammation modulation, and tissue regeneration. We welcome strategic collaborations with pharmaceutical companies, biotech innovators, academic institutions, clinical centers, and regional development partners.

1)A differentiated natural MSC-exosome platform with functional subpopulation biology, scalable CMC, and early human signal

Partnership Opportunities in Inflammation, Regeneration, and Platform Access

  • Co-development of S1 / S2 programs by indication
  • Regional or global development collaborations
  • Platform access and strategic licensing
  • CMC / QC differentiation for natural vesicle programs
Best-fit partners
  • Companies focused on immunology, respiratory, inflammation, regenerative medicine, and cardiovascular indications
  • RP-ILD, AE-COPD, IBD, stroke, heart failure and related programs
2)An integrated platform combining brain access, neuronal delivery, functional RNAi knockdown activity, repeat-dose feasibility, and scalable manufacturing

Partnering Opportunities in CNS RNA Therapeutics and Platform Access

  • Co-development of CNS RNA therapeutics
  • Platform access for partner payloads / targets
  • Strategic research collaborations and licensing
Best-fit partners
  • Companies pursuing validated CNS targets where delivery remains the bottleneck
  • AD, PD, ALS, HD and related CNS programs

Get in Touch

Tinghe Wu, Ph.D.
CEO
wuth@pskbio.com; 86-180-6702-9687
John Z. Zhu, Ph.D.
VP, Global Strategy and BD
johnzzhu@pskbio.com; 484-588-8030
Business Development
Partnerships, licensing, and global BD inquiries
CEO & Founder
Strategic and scientific collaboration inquiries

Send a Message

Our team will get back to you within 2 business days.

We will get back to you within 2 business days.